 |
Enterprise through
ISO9001、 ISO14001
ISO45001、ISO13485
System authentication |
|
|
| |
| An xxxxxxxxxxxxxxxxx |
test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test test
|
|
| |
| |
| SARS-CoV-2 Rapid Test Kit |
|
| |
|
Novel Coronavirus(SARS-Cov-2) Antigen Test
COVID-19 Antigen Rapid Test Kit is a solid phase immunochromatographic assay for the in vitro
qualitative detection of antigen to 2019 Novel Coronavirus in human nasopharyngeal secretion or
oropharyngeal secretion. This test kit provides only a preliminary test result for COVID-19
infection as a clinically-assisted diagnosis. The test kit is applicable to clinical system, medical
institutions and scientific research field.
Features & Benets
■ Specimen type:Nasal Aspirate Fluid/Nasal Swab/
■ Easy to collect samples,simple operation,
without professional equipment and laboratory
■ Testing time:15 minutes
■ convenient transportation
■ Applicable to self- testing at home |
|
|
|
| |
|
|
|
Covid-19 IgG/IgM Test kit
COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma)
is a solid phase immunochromatographic assay for the rapid,
qualitative and differential detection of IgG and IgM antibodies to 2019
Novel Coronavirus in human whole blood, serum or plasma.
Features & Benets
■ Specimen type:Whole Blood/Serum/Plasma
■ Facilitates patient treatment decisions quickly
■ Little specimens, only 5 µL of serum/plasma
or 10 µL of whole blood specimens
■ All necessary reagents provided & no professional
equipment needed
■ Relative Sensitivity:96.88% Relative Specificity:100%
Overall Agreement:99%
|
|
| |
| |
|
SARS-CoV-2 Neutralizing Antibody Rapid Test Kit
SARS-CoV-2 Neutralizing Antibody Rapid Test Kit
(Whole Blood/Serum/Plasma) is a solid phase immunochromatographic
assay for the in vitro qualitative detection of neutralizing antibody in
human serum, plasma and whole blood after accination against 2019-nCoV.
This product is designed to determine whether people have produced
neutralizing antibody after being vaccinated with 2019-nCoV vaccine.
Features & Benets
Test time: 15 minutes
Specimen：Whole blood/Serum/Plasma
Sensitivity：96.5%
Specificity: 99%%
|
|
|
|
| |
| Technical Comparison |
|
Fluorescence PCR |
ELISA |
Colloidal Gold method |
Colloidal Gold method |
| Detection substance |
Nucleic acid |
Antibody |
Antibody |
Antigen |
| Type of sample |
nasopharyngeal swabs,sputum,alveolar lavage fluid |
Serum/plasma |
serum/plasma/whole blood |
Nasal/Throat Swab |
| Time to get result |
2 hrs |
1 hrs |
Fastest 10 minutes |
15 minutes |
| Instrument needed or not |
Yes |
Yes |
No |
No |
| Laboratory requirement |
Confirming diagnosis |
Nucleic acid negative sample reviewing or high-volume
sample detection |
Nucleic acid negative sample reviewing or basic hospital sample testing |
Early
Diagnosis |
|
| |
| |
>
| Procuct Paramters |
| Product |
Specimen |
Packing |
Reg. |
| SARS-CoV-2 Antigen |
Oropharyngeal
Nasopharyngeal |
1pcs/Box,25pcs/Box |
CE,Anvisa,Bfarm |
| SARS-CoV-2 Antigen(saliva) |
Saliva |
1pcs/Box,25pcs/Box |
CE,Anvisa,Bfarm |
| Covid-19 IgG/IgM Test kit |
WB/S/P |
25pcs/Box |
CE,Anvisa |
| SARS-CoV-2 Neutralizing Antibody |
WB/S/P |
25pcs/Box |
CE |
|
| |
>
| Ordering Info |
| Model No |
Product Name |
Pack Size |
Validity |
| ECOV-01 |
Covid-19 IgG/IgM Antibody RapidTest kit |
25T/kit |
24 months at 2-30℃ |
| ECOV-02 |
SARS-CoV-2 Antigen Rapid Test |
1T/kit,25T/kit |
24 months at 2-30℃ |
| ECOV-03 |
SARS-CoV-2 Neutralizing Antibody Rapid Test Kit |
25T/kit |
24 months at 2-30℃ |
|
| |
|
|
| |
|
NanTong Egens Biotechnology Co.,Ltd
Add:Building 15, Building 12(west) No. 1692 Xinghu Avenue
Nantong Economy & Technology Development Zone
226010 Nantong Jiangsu Province, China.
Tel: +86-513-85920700
+86-513-85356913
E-mail:egens@egens-bio.com
Get more clinical information，click on the URL below.
http://www.egens-bio.com/
|
 |
| |
|
|
| |
| About Us |
|
| |
Nantong Egens Biotechnology Co.,LTd
Egens Biotechnology Co.,Ltd was founded in 1999. It’s a collection of biological raw materials
development, diagnostic reagent manufacturing, domestic and foreign trade in one of the comprehensive biotechnology company. Early pregnancy multi-function detection reagent, COVID-19
antigen detection kit and other products are mainly used in home self-examination, drug detection,
clinical detection and other fields..
.
Nantong Egens Biotechnology Co.,Ltd has more than 600 employees ,30000 square meters spare
standby plants in Nantong Free Trade Zone, 25000 square meters purification production workshop and more than 200 sets of automatic flow production line and has more than one hundred
products sFDA licensed ..
.
Nantong Egens Biotechnology Co.,Ltd is capable of complete supply chain, perfect quality management system, strong production capacity and excellent global marketing team..
.
Nantong Egens Biotechnology Co.,Ltd obtained 13 national invention patents of HCG multi-function detection reagent, LH quantitative detection system, dual-channel automatic quantitative
detector and other, 12 utility model patents and dozens of patents under review..
.
Beijing Kewei Clinical Diagnostic Reagents.
Beijing Kewei Clinical Diagnostic Reagents Manufacturer was established with the technology and
resource advantages of 302 Hospital of the P.L.A.in 1990 ,it is one of the earliest companies
specialized in producing diagnostic reagents. 302 Hospital of P.L.A. is one of the largest domestic
infectious hospitals with many famous clinical and diagnostic experts. At present, Kewei has
obtained GMP certificate and has a 3000 square meter clean room meeting GMP requirements
that laid the reliable foundation for good product quality. .
.
Kewei has a professional and experienced sales team. The Domestic and International market
sales volume increases rapidly each year, is the superior positions in blood screening tests for
infectious diseases in China. Our marketing efforts extend to the fields of clinical testing, disease
control and prevention, blood screening etc..
Since the year 2013, Beijing Kewei Clinical Diagnostic Reagent Co.,Ltd has been a wholly
-owned subsidiary of Nantong Egens Biotechnology Co.,Ltd.
|
| |
|